Skip to main content
SpringerLink
Log in

Adalimumab/Certolizumab-pegol

Relapsing Polychondritis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Icacan OC, et al. Relapsing Polychondritis in a Patient with Ankylosing Spondylitis under Two Different Tumor Necrosis Factor Alpha Inhibitors Treatment. Clinica Terapeutica 173: 97-98, No. 2, 4 Apr 2022. Available from: URL: http://doi.org/10.7417/CT.2022.2400

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/Certolizumab-pegol. Reactions Weekly 1908, 21 (2022). https://doi.org/10.1007/s40278-022-15749-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-15749-6

Search

Navigation